• CRISPR Therapeutics (NASDAQ:CRSP) Given New $57.00 Price Target at The Goldman Sachs Group

    Source: Buzz FX / 13 Feb 2025 11:51:11   America/Chicago


    CRISPR Therapeutics (NASDAQ:CRSP) Given New $57.00 Price Target at The Goldman Sachs Group Written by MarketBeat February 13, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) had its price target cu
    Read more...
Share on,